Jiangsu Simcere Pharmaceutical Co., Ltd. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.
- Minor: SIM0278 · Moderate to Severe Atopic Dermatitis Trial status changed: Not Yet Recruiting → Active, Not Recruiting
- Minor: SIM0811 Injection in Healthy Chinese Adult Participants Trial completed
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-03 | NCT07912268 Study of SIM0518 in Participants With ALK-Positive or ROS1-Positive Locally Advanced or… | Phase 1 | Not Yet Recruiting |
| 2026-10-29 | NCT07903701 A Phase II/III Clinical Study of SIM0811 in the Treatment of Acute Ischemic Stroke | Phase 2/3 | Not Yet Recruiting |
Active trials by phase
| Phase 1 | 15 | |
| Phase 2 | 1 | |
| Phase 2/3 | 1 | |
| Phase 3 | 4 |
Disease areas by active trials, top 10 of 12
Lung Cancer (3) · Breast Cancer (2) · Colorectal Cancer (2) · Non-Small Cell Lung Cancer (NSCLC) (2) · Atopic Dermatitis (1) · Bladder Cancer (1) · Head & Neck Cancer (1) · Liver Cancer (1) · Multiple Myeloma (1) · Non-Hodgkin Lymphoma (1)
Get alerts when Jiangsu Simcere Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.